OpenURL Connection Search

Select item for more details and to access through your institution.

Plasma Sex Steroid Transport and Histamine H2-Receptor Antagonists.
Published in:
Annals of the New York Academy of Sciences, 1988, v. 538, n. 1, p. 304, doi. 10.1111/j.1749-6632.1988.tb48874.x
By:
- BERTA, L.;
- DUSIO, P.;
- FORTUNATI, N.;
- FAZZARI, A.;
- CRUA, M. R.;
- FRAIRIA, R.;
- GAIDANO, G.
Publication type:
Article
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion.
Published in:
2001
By:
- Rigamonti, C;
- Volta, C;
- Colombi, S;
- Forti, L;
- Savinelli, F;
- Gaidano, G;
- Bartoli, E
Publication type:
Case Study
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma.
Published in:
2000
By:
- Carbone, A;
- Cilia, A M;
- Gloghini, A;
- Capello, D;
- Fassone, L;
- Perin, T;
- Rossi, D;
- Canzonieri, V;
- De Paoli, P;
- Vaccher, E;
- Tirelli, U;
- Volpe, R;
- Gaidano, G
Publication type:
journal article
MUM1: a step ahead toward the understanding of lymphoma histogenesis.
Published in:
2000
By:
- Gaidano, G;
- Carbone, A
Publication type:
Editorial
Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes.
Published in:
2000
By:
- Capello, D;
- Fais, F;
- Vivenza, D;
- Migliaretti, G;
- Chiorazzi, N;
- Gaidano, G;
- Ferrarini, M
Publication type:
journal article
Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma.
Published in:
2000
By:
- Fassone, L;
- Bhatia, K;
- Gutierrez, M;
- Capello, D;
- Gloghini, A;
- Dolcetti, R;
- Vivenza, D;
- Ascoli, V;
- Coco, F Lo;
- Pagani, L;
- Dotti, G;
- Rambaldi, A;
- Raphael, M;
- Tirelli, U;
- Saglio, G;
- Magrath, I T;
- Carbone, A;
- Gaidano, G;
- Lo Coco, F
Publication type:
journal article
The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma.
Published in:
2000
By:
- Capello, D;
- Gaidano, G;
- Gallicchio, M;
- Gloghini, A;
- Medico, E;
- Vivenza, D;
- Buonaiuto, D;
- Fassone, L;
- Avanzi, G C;
- Saglio, G;
- Prat, M;
- Carbone, A
Publication type:
journal article
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas.
Published in:
1999
By:
- Fais, F;
- Gaidano, G;
- Capello, D;
- Gloghini, A;
- Ghiotto, F;
- Roncella, S;
- Carbone, A;
- Chiorazzi, N;
- Ferrarini, M
Publication type:
journal article
Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines.
Published in:
1999
By:
- Drexler, H G;
- Meyer, C;
- Gaidano, G;
- Carbone, A
Publication type:
journal article
Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas).
Published in:
1998
By:
- Drexler, H G;
- Uphoff, C C;
- Gaidano, G;
- Carbone, A
Publication type:
journal article
HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas.
Published in:
1998
By:
- Uphoff, C.C.;
- Habig, S.;
- Carbone, A.;
- Gaidano, G.;
- Drexler, H.G.
Publication type:
journal article
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)
Published in:
2012
By:
- Rigacci L;
- Puccini B;
- Cortelazzo S;
- Gaidano G;
- Piccin A;
- D'Arco A;
- Freilone R;
- Storti S;
- Orciuolo E;
- Zinzani PL;
- Zaja F;
- Bongarzoni V;
- Balzarotti M;
- Rota-Scalabrini D;
- Patti C;
- Gobbi M;
- Carpaneto A;
- Liberati AM;
- Bosi A;
- Iannitto E
Publication type:
Journal Article
Pituitary-Gonadal Status, and Genetic, Constitutional, and Environmental Factors in Italian Premenopausal Healthy Women with Respect to Breast Cancer Risk: Preliminary Results.
Published in:
Annals of the New York Academy of Sciences, 1986, v. 464, n. 1, p. 466, doi. 10.1111/j.1749-6632.1986.tb16038.x
By:
- BERTA, L.;
- BALLARIS, A.;
- BONINO, L.;
- BORIO, F.;
- BRIGNARDELLO, E.;
- DONVITO, V.;
- FORTUNATI, N.;
- RAVIZZA, M.;
- GAIDANO, G. P.
Publication type:
Article
Circulating malignant precursors in monoclonal gammopathies.
Published in:
European Journal of Haematology, 1989, v. 43, n. S51, p. 27, doi. 10.1111/j.1600-0609.1989.tb01488.x
By:
- Caligaris-Cappio, F.;
- Bergui, L.;
- Gaidano, G. L.;
- Schena, M.;
- Putto, P.;
- Merico, F.;
- Riva, M.
Publication type:
Article
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.
Published in:
Leukemia (08876924), 2015, v. 29, n. 6, p. 1360, doi. 10.1038/leu.2015.21
By:
- Mauro, F R;
- Chauvie, S;
- Paoloni, F;
- Biggi, A;
- Cimino, G;
- Rago, A;
- Gentile, M;
- Morabito, F;
- Coscia, M;
- Bellò, M;
- Sacchetti, G M;
- Rossi, D;
- Laurenti, L;
- Autore, F;
- Campanelli, M;
- Trastulli, F;
- Nicolai, E;
- Riminucci, M;
- Gaidano, G;
- Guarini, A
Publication type:
Article
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2014, v. 28, n. 5, p. 1060, doi. 10.1038/leu.2013.319
By:
- Arruga, F;
- Gizdic, B;
- Serra, S;
- Vaisitti, T;
- Ciardullo, C;
- Coscia, M;
- Laurenti, L;
- D'Arena, G;
- Jaksic, O;
- Inghirami, G;
- Rossi, D;
- Gaidano, G;
- Deaglio, S
Publication type:
Article
CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34(+) hemopoietic progenitors cells.
Published in:
2014
By:
- Rossi, F M;
- Zucchetto, A;
- Tissino, E;
- Dal Bo, M;
- Bomben, R;
- Caldana, C;
- Pozzo, F;
- Del Poeta, G;
- Rossi, D;
- Gaidano, G;
- Gattei, V
Publication type:
Letter
CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34+ hemopoietic progenitors cells.
Published in:
Leukemia (08876924), 2014, v. 28, n. 3, p. 705, doi. 10.1038/leu.2013.331
By:
- Rossi, F M;
- Zucchetto, A;
- Tissino, E;
- Dal Bo, M;
- Bomben, R;
- Caldana, C;
- Pozzo, F;
- Del Poeta, G;
- Rossi, D;
- Gaidano, G;
- Gattei, V
Publication type:
Article
CD38 signals upregulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells.
Published in:
Leukemia (08876924), 2013, v. 27, n. 5, p. 1177, doi. 10.1038/leu.2012.260
By:
- Vaisitti, T;
- Serra, S;
- Pepper, C;
- Rossi, D;
- Laurenti, L;
- Gaidano, G;
- Malavasi, F;
- Deaglio, S
Publication type:
Article
CD38 signals upregulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells.
Published in:
2013
By:
- Vaisitti, T;
- Serra, S;
- Pepper, C;
- Rossi, D;
- Laurenti, L;
- Gaidano, G;
- Malavasi, F;
- Deaglio, S
Publication type:
Journal Article
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients.
Published in:
2013
By:
- Falco, P;
- Cavallo, F;
- Larocca, A;
- Rossi, D;
- Guglielmelli, T;
- Rocci, A;
- Grasso, M;
- Siez, M L M;
- De Paoli, L;
- Oliva, S;
- Molica, S;
- Mina, R;
- Gay, F;
- Benevolo, G;
- Musto, P;
- Omedè, P;
- Freilone, R;
- Bringhen, S;
- Carella, A M;
- Gaidano, G
Publication type:
Journal Article
Lenalidomide−prednisone induction followed by lenalidomide−melphalan−prednisone consolidation and lenalidomide−prednisone maintenance in newly diagnosed elderly unfit myeloma patients.
Published in:
Leukemia (08876924), 2013, v. 27, n. 3, p. 695, doi. 10.1038/leu.2012.271
By:
- Falco, P;
- Cavallo, F;
- Larocca, A;
- Rossi, D;
- Guglielmelli, T;
- Rocci, A;
- Grasso, M;
- Siez, M L M;
- De Paoli, L;
- Oliva, S;
- Molica, S;
- Mina, R;
- Gay, F;
- Benevolo, G;
- Musto, P;
- Omedè, P;
- Freilone, R;
- Bringhen, S;
- Carella, A M;
- Gaidano, G
Publication type:
Article
The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
Published in:
2012
By:
- Bomben R;
- Gobessi S;
- Dal Bo M;
- Volinia S;
- Marconi D;
- Tissino E;
- Benedetti D;
- Zucchetto A;
- Rossi D;
- Gaidano G;
- Del Poeta G;
- Laurenti L;
- Efremov DG;
- Gattei V;
- Bomben, R;
- Gobessi, S;
- Dal Bo, M;
- Volinia, S;
- Marconi, D;
- Tissino, E
Publication type:
journal article
The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
Published in:
Leukemia (08876924), 2012, v. 26, n. 7, p. 1584, doi. 10.1038/leu.2012.44
By:
- Bomben, R;
- Gobessi, S;
- Dal Bo, M;
- Volinia, S;
- Marconi, D;
- Tissino, E;
- Benedetti, D;
- Zucchetto, A;
- Rossi, D;
- Gaidano, G;
- Del Poeta, G;
- Laurenti, L;
- Efremov, D G;
- Gattei, V
Publication type:
Article
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.
Published in:
Leukemia (08876924), 2012, v. 26, n. 6, p. 1301, doi. 10.1038/leu.2011.369
By:
- Zucchetto, A;
- Vaisitti, T;
- Benedetti, D;
- Tissino, E;
- Bertagnolo, V;
- Rossi, D;
- Bomben, R;
- Dal Bo, M;
- Del Principe, M I;
- Gorgone, A;
- Pozzato, G;
- Gaidano, G;
- Del Poeta, G;
- Malavasi, F;
- Deaglio, S;
- Gattei, V
Publication type:
Article
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.
Published in:
Leukemia (08876924), 2011, v. 25, n. 8, p. 1268, doi. 10.1038/leu.2011.88
By:
- Ferretti, E.;
- Bertolotto, M.;
- Deaglio, S.;
- Tripodo, C.;
- Ribatti, D.;
- Audrito, V.;
- Blengio, F.;
- Matis, S.;
- Zupo, S.;
- Rossi, D.;
- Ottonello, L.;
- Gaidano, G.;
- Malavasi, F.;
- Pistoia, V.;
- Corcione, A.
Publication type:
Article
E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2011, v. 25, n. 3, p. 479, doi. 10.1038/leu.2010.291
By:
- Saborit-Villarroya, I.;
- Vaisitti, T.;
- Rossi, D.;
- D'Arena, G.;
- Gaidano, G.;
- Malavasi, F.;
- Deaglio, S.
Publication type:
Article
CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.
Published in:
Leukemia (08876924), 2010, v. 24, n. 5, p. 958, doi. 10.1038/leu.2010.36
By:
- Vaisitti, T.;
- Aydin, S.;
- Rossi, D.;
- Cottino, F.;
- Bergui, L.;
- D'Arena, G.;
- Bonello, L.;
- Horenstein, A. L.;
- Brennan, P.;
- Pepper, C.;
- Gaidano, G.;
- Malavasi, F.;
- Deaglio, S.
Publication type:
Article
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21.
Published in:
Leukemia (08876924), 2009, v. 23, n. 6, p. 1118, doi. 10.1038/leu.2008.398
By:
- Rossi, D.;
- Rasi, S.;
- Franceschetti, S.;
- Capello, D.;
- Castelli, A.;
- De Paoli, L.;
- Ramponi, A.;
- Chiappella, A.;
- Pogliani, E. M.;
- Vitolo, U.;
- Kwee, I.;
- Bertoni, F.;
- Conconi, A.;
- Gaidano, G.
Publication type:
Article
Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10.
Published in:
2008
By:
- Benedetti, D.;
- Bomben, R.;
- Dal-Bo, M.;
- Marconi, D.;
- Zucchetto, A.;
- Degan, M.;
- Forconi, F.;
- Del-Poeta, G.;
- Gaidano, G.;
- Gattei, V.
Publication type:
Letter
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma.
Published in:
2005
By:
- Rossi, D.;
- Cerri, M.;
- Capello, D.;
- Deambrogi, C.;
- Berra, E.;
- Franceschetti, S.;
- Alabiso, O.;
- Gloghini, A.;
- Paulli, M.;
- Carbone, A.;
- Pileri, S.A.;
- Pasqualucci, L.;
- Gaidano, G.
Publication type:
Letter
Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2004, v. 18, n. 12, p. 1941, doi. 10.1038/sj.leu.2403537
By:
- Capello, D;
- Guarini, A;
- Berra, E;
- Mauro, F. R.;
- Rossi, D.;
- Ghia, E.;
- Cerri, M.;
- Logan, J.;
- Foà, R.;
- Gaidano, G.
Publication type:
Article
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.
Published in:
2009
By:
- Dal-Bo M;
- Bertoni F;
- Forconi F;
- Zucchetto A;
- Bomben R;
- Marasca R;
- Deaglio S;
- Laurenti L;
- Efremov DG;
- Gaidano G;
- Del Poeta G;
- Gattei V;
- Dal-Bo, Michele;
- Bertoni, Francesco;
- Forconi, Francesco;
- Zucchetto, Antonella;
- Bomben, Riccardo;
- Marasca, Roberto;
- Deaglio, Silvia;
- Laurenti, Luca
Publication type:
journal article
SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN PATIENTS WITH DLBCL. A MULTICENTER, OPEN‐LABEL, PHASE II TRIAL.
Published in:
Hematological Oncology, 2023, v. 41, p. 165, doi. 10.1002/hon.3163_T01
By:
- Stathis, A.;
- Hitz, F.;
- Schär, S.;
- Novak, U.;
- Fischer, N.;
- Mey, U.;
- Gritti, G.;
- Zander, T.;
- Lang, N.;
- Cairoli, A.;
- Zenz, T.;
- Rhyner, G.;
- Mingrone, W.;
- Schmidt, A.;
- Gaidano, G.;
- Hohaus, S.;
- Stern, A. O.;
- Mamot, C.;
- Bruscagin, A.;
- Musilova, J.
Publication type:
Article
Five‐year subgroup analysis of tafasitamab + lenalidomide from the Phase II L‐MIND study in patients with relapsed or refractory diffuse large B‐cell lymphoma.
Published in:
Hematological Oncology, 2023, v. 41, p. 439, doi. 10.1002/hon.3164_324
By:
- Duell, J.;
- Abrisqueta, P.;
- Dreyling, M.;
- Gaidano, G.;
- Barca, E. G.;
- Jurczak, W.;
- Maddocks, K. J.;
- Menne, T.;
- Nagy, Z.;
- Tournilhac, O.;
- Bakuli, A.;
- Amin, A.;
- Gurbanov, K.;
- Salles, G.
Publication type:
Article
Five‐year efficacy and safety of tafasitamab in patients with relapsed or refractory DLBCL: Final results from the Phase II L‐MIND study.
Published in:
Hematological Oncology, 2023, v. 41, p. 437, doi. 10.1002/hon.3164_323
By:
- Duell, J.;
- Abrisqueta, P.;
- Andre, M.;
- Augustin, M.;
- Gaidano, G.;
- Barca, E. G.;
- Jurczak, W.;
- Kalakonda, N.;
- Liberati, A. M.;
- Maddocks, K. J.;
- Menne, T.;
- Nagy, Z.;
- Tournilhac, O.;
- Bakuli, A.;
- Amin, A.;
- Gurbanov, K.;
- Salles, G.
Publication type:
Article
EFFICACY AND SAFETY OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME.
Published in:
Hematological Oncology, 2023, v. 41, p. 62, doi. 10.1002/hon.3163_27
By:
- Frustaci, A. M.;
- Montillo, M.;
- Rossi, D.;
- Zinzani, P. L.;
- Motta, M.;
- Gaidano, G.;
- Quaresmini, G.;
- Scarfò, L.;
- Pietrasanta, D.;
- Coscia, M.;
- Deodato, M.;
- Zamprogna, G.;
- Cairoli, R.;
- Stüssi, G.;
- Zucca, E.;
- Pileri, S.;
- Zenz, T.;
- Tedeschi, A.
Publication type:
Article
PRIMARY EXTRANODAL FOLLICULAR LYMPHOMA IN A LARGE RETROSPECTIVE SURVEY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG31)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.78_2879
By:
- Conconi, A.;
- Vannata, B.;
- Janikova, A.;
- Ramirez, A.;
- Bodoni, C. Lobetti;
- Nowakowski, G.;
- Mian, M.;
- Ferreri, Andrés J.M.;
- Ryan, G.;
- Pangalis, G. A.;
- Cabrera, M. E.;
- Luminari, S.;
- Montoto, S.;
- Tsang, R.;
- Aurer, I.;
- Visco, C.;
- Mazzucchelli, L.;
- Trneny, M.;
- Gaidano, G.;
- Federico, M.
Publication type:
Article
DISSECTING THE GENETICS OF DIFFERENT ANATOMICAL COMPARTMENTS OF SMALL LYMPHOCYTIC LYMPHOMA WITH A MULTIREGIONAL SEQUENCING APPORACH.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.54_2880
By:
- Moia, R.;
- Favini, C.;
- Ferri, V.;
- Terdi Di Bergamo, L.;
- Schipani, M.;
- Forestieri, G.;
- Sagiraju, S.;
- Andorno, A.;
- Rasi, S.;
- Talotta, D.;
- Al Essa, W.;
- Adhinaveni, R.;
- Bruscaggin, A.;
- Spina, V.;
- De Paoli, L.;
- Margiotta Casaluci, G.;
- Patriarca, A.;
- Boldorini, R. L.;
- Rossi, D.;
- Gaidano, G.
Publication type:
Article
INTENSIFIED (INTRAVENOUS AND INTRATHECAL) CNS PROPHYLAXIS IN PRIMARY TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: 5‐YEAR RESULTS OF THE IELSG30 TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.48_2879
By:
- Conconi, A.;
- Chiappella, A.;
- Orsucci, L.;
- Gaidano, G.;
- Ferreri, Andrés J.M.;
- Balzarotti, M.;
- Tucci, A.;
- Botto, B.;
- Moccia, A.;
- Vanazzi, A.;
- Merli, F.;
- Tani, M.;
- Esposito, F.;
- Bonomini, L.;
- Vitolo, U.;
- Zucca, E.
Publication type:
Article
MOLTO, A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II CLINICAL TRIAL ON VENETOCLAX, ATEZOLIZUMAB, OBINUTUZUMAB IN RICHTER TRANSFORMATION: SAFETY INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.40_2880
By:
- Frustaci, A. M.;
- Tedeschi, A.;
- Zinzani, P. L.;
- Pietrasanta, D.;
- Coscia, M.;
- Zenz, T.;
- Motta, M.;
- Gaidano, G.;
- Scarfò, L.;
- Deodato, M.;
- Zamprogna, G.;
- Vitale, C.;
- Cairoli, R.;
- Rossi, D.;
- Montillo, M.
Publication type:
Article
LONG‐TERM ANALYSES FROM L‐MIND, A PHASE II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.28_2879
By:
- Duell, J;
- Maddocks, K. J;
- González‐Barca, E;
- Jurczak, W;
- Liberati, A. M;
- Obr, A;
- Gaidano, G;
- Abrisqueta, P;
- André, M;
- Dreyling, M;
- Menne, T;
- Dirnberger‐Hertweck, M.;
- Weirather, J;
- Ambarkhane, S;
- Salles, G
Publication type:
Article
PHASED VARIANTS IMPROVE DLBCL MINIMAL RESIDUAL DISEASE DETECTION AT THE END OF THERAPY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.25_2879
By:
- Kurtz, D. M;
- Chabon, J. J;
- Soo, J;
- Co Ting Keh, L;
- Alig, S;
- Schultz, A;
- Jin, M. C;
- Scherer, F;
- Craig, A. F. M;
- Liu, C. L;
- Dührsen, U;
- Hüttmann, A;
- Casasnovas, R.‐O;
- Westin, J. R;
- Roschewski, M;
- Wilson, W. H;
- Gaidano, G;
- Rossi, D;
- Diehn, M;
- Alizadeh, A. A
Publication type:
Article
THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 110, doi. 10.1002/hon.72_2629
By:
- Tiacci, E.;
- De Carolis, L.;
- Simonetti, E.;
- Zaja, F.;
- Capponi, M.;
- Ambrosetti, A.;
- Lucia, E.;
- Antolino, A.;
- Pulsoni, A.;
- Ferrari, S.;
- Zinzani, P.;
- Rigacci, L.;
- Gaidano, G.;
- Della Seta, R.;
- Frattarelli, N.;
- Falcucci, P.;
- Visani, G.;
- Foà, R.;
- Falini, B.
Publication type:
Article
PET‐DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL).
Published in:
Hematological Oncology, 2019, v. 37, p. 253, doi. 10.1002/hon.62_2630
By:
- Balzarotti, M.;
- Ricardi, U.;
- Spina, M.;
- Monagheddu, C.;
- Tucci, A.;
- Cavallo, F.;
- Zanni, M.;
- Arcari, A.;
- Rusconi, C.;
- Sartori, R.;
- Merli, F.;
- Re, F.;
- Vitolo, U.;
- Dessi, D.;
- Melis, L.;
- Gaidano, G.;
- Chiti, A.;
- Deidda, M.;
- Santoro, A.;
- Ciccone, G.
Publication type:
Article
EARLY PROGRESSION OF DISEASE (POD24) PREDICTS SHORTER SURVIVAL IN MALT LYMPHOMA PATIENTS RECEIVING SYSTEMIC TREATMENT.
Published in:
Hematological Oncology, 2019, v. 37, p. 179, doi. 10.1002/hon.136_2629
By:
- Conconi, A.;
- Thieblemont, C.;
- Cascione, L.;
- Torri, V.;
- Kiesewetter, B.;
- Margiotta‐Casaluci, G.;
- Gaidano, G.;
- Raderer, M.;
- Cavalli, F.;
- Lopez Guillermo, A.;
- Johnson, P.W.;
- Zucca, E.
Publication type:
Article
PRIMARY ANALYSIS RESULTS OF THE SINGLE‐ARM PHASE II STUDY OF MOR208 PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (L‐MIND).
Published in:
Hematological Oncology, 2019, v. 37, p. 173, doi. 10.1002/hon.130_2629
By:
- Salles, G.;
- Duell, J.;
- González Barca, E.;
- Jurczak, W.;
- Liberati, A.M.;
- Nagy, Z.;
- Obr, A.;
- Gaidano, G.;
- Andre, M.;
- Kalakonda, N.;
- Dreyling, M.;
- Zinzani, P.L.;
- Dirnberger‐Hertweck, M.;
- Weirather, J.;
- Ambarkhane, S.;
- Maddocks, K.
Publication type:
Article
THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 110, doi. 10.1002/hon.72_2629
By:
- Tiacci, E.;
- De Carolis, L.;
- Simonetti, E.;
- Zaja, F.;
- Capponi, M.;
- Ambrosetti, A.;
- Lucia, E.;
- Antolino, A.;
- Pulsoni, A.;
- Ferrari, S.;
- Zinzani, P.;
- Rigacci, L.;
- Gaidano, G.;
- Della Seta, R.;
- Frattarelli, N.;
- Falcucci, P.;
- Visani, G.;
- Foà, R.;
- Falini, B.
Publication type:
Article
PET‐DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL).
Published in:
Hematological Oncology, 2019, v. 37, p. 253, doi. 10.1002/hon.62_2630
By:
- Balzarotti, M.;
- Ricardi, U.;
- Spina, M.;
- Monagheddu, C.;
- Tucci, A.;
- Cavallo, F.;
- Zanni, M.;
- Arcari, A.;
- Rusconi, C.;
- Sartori, R.;
- Merli, F.;
- Re, F.;
- Vitolo, U.;
- Dessi, D.;
- Melis, L.;
- Gaidano, G.;
- Chiti, A.;
- Deidda, M.;
- Santoro, A.;
- Ciccone, G.
Publication type:
Article
EARLY PROGRESSION OF DISEASE (POD24) PREDICTS SHORTER SURVIVAL IN MALT LYMPHOMA PATIENTS RECEIVING SYSTEMIC TREATMENT.
Published in:
Hematological Oncology, 2019, v. 37, p. 179, doi. 10.1002/hon.136_2629
By:
- Conconi, A.;
- Thieblemont, C.;
- Cascione, L.;
- Torri, V.;
- Kiesewetter, B.;
- Margiotta‐Casaluci, G.;
- Gaidano, G.;
- Raderer, M.;
- Cavalli, F.;
- Lopez Guillermo, A.;
- Johnson, P.W.;
- Zucca, E.
Publication type:
Article

Found: 62